A Randomized, Open-Label, Safety and Exploratory Efficacy Study of Kanglaite Injection (KLTi) plus Gemcitabine versus Gemcitabine in Patients with Advanced Pancreatic Cancer.
about
A Randomized, Open-Label, Safety and Exploratory Efficacy Study of Kanglaite Injection (KLTi) plus Gemcitabine versus Gemcitabine in Patients with Advanced Pancreatic Cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
A Randomized, Open-Label, Safe ...... th Advanced Pancreatic Cancer.
@en
type
label
A Randomized, Open-Label, Safe ...... th Advanced Pancreatic Cancer.
@en
prefLabel
A Randomized, Open-Label, Safe ...... th Advanced Pancreatic Cancer.
@en
P2093
P2860
P356
P1433
P1476
A Randomized, Open-Label, Safe ...... th Advanced Pancreatic Cancer.
@en
P2093
Bryan J Bienvenu
Edward H Kaplan
Francis P Arena
J Paul Waymack
Lee S Schwartzberg
Luis H Camacho
Luis T Campos
Mary A Tagliaferri
Michael M Chen
P2860
P304
P356
10.7150/JCA.15407
P577
2017-07-03T00:00:00Z